分析与乙型肝炎病毒相关的肝细胞癌
1Clifton College, Bristol, UK.
Journal of cellular and molecular medicine
|July 30, 2023
概括
乙型肝炎病毒 (HBV) 通过改变细胞通路来驱动肝癌 (HCC). 诸如核类药物和PEGylated干扰素α等治疗方法可以改善结果,降低与HBV相关的HCC发病率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 在瘤学瘤学.
背景情况:
- 乙型肝炎病毒 (HBV) 是肝细胞癌 (HCC) 的主要原因.
- 乙型肝炎病毒感染肝细胞,导致细胞亡,肝硬化和癌症.
- 病毒蛋白可以破坏宿主细胞的亡,促进不受控制的肝细胞增殖.
研究的目的:
- 研究HBV引起肝癌的机制.
- 审查慢性和急性HBV感染的当前治疗方法.
- 了解HBV在肝细胞癌发展中的作用.
主要方法:
- 关于HBV感染机制的文献综述.
- 分析宿主细胞通路中的病毒蛋白功能.
- 对当前HBV治疗策略的评估.
主要成果:
- 乙型肝炎病毒的复制会诱导亡,并可能导致肝硬化和癌症.
- 病毒蛋白与P53或P13K/AKT通路的相互作用阻止了亡,促进了瘤的生长.
- 核糖类类似物 (NA) 和PEGylated干扰素-α (PegIFN-α) 是常见的治疗方法,具有不同的疗效和副作用.
结论:
- 乙型肝炎病毒感染对HCC发展构成重大风险.
- 有效的治疗方法可用,但像NA的低血清转化率这样的挑战仍然存在.
- 医学和疫苗的进步降低了与HBV相关的HCC发病率和死亡率.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


